• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
LNTH

LNTH

Lantheus Holdings, Inc.

NASDAQHealthcareDrug Manufacturers - Specialty & GenericUS

USD100.25

+3.95 (+4.10%)

Rating:A

Company Profile

CEO

Mary Anne Heino

IPO Date

2015-06-25

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

Country

US

Market Metrics

Open

$96.46

Prev. Close

$96.30

Day Low

$95.00

Day High

$101.66

52W Low

$47.25

52W High

$103.89

Market Cap

$6.53B

Volume

1.07M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

52.4%

Avg Negative

2.8%

Avg Neutral

44.6%

News Feed

Lantheus Announces the First and Only FDA Cleared AI-Enabled PSMA Digital Application, aPROMISE™, Strengthening Lantheus' Leadership in Prostate Cancer

Business Wire·7/29/2021·↑ positive

Lantheus Holdings: Q2 Earnings Insights

Benzinga·7/28/2021·↑ positive

Lantheus Holdings, Inc. (LNTH) CEO Mary Anne Heino on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha
·7/28/2021
·↓ negative

Lantheus Holdings (LNTH) Q2 Earnings and Revenues Beat Estimates

Zacks Investment Research·7/28/2021·↑ positive

Lantheus Holdings to Host Second Quarter 2021 Earnings Conference Call and Webcast on July 28, 2021 at 8:00 a.m. Eastern Time

Business Wire·7/14/2021·↑ positive

Lantheus Holdings: PYLARIFY Approval Revitalizes My Bullish Outlook

Seeking Alpha·6/18/2021·↑ positive

Lantheus Holdings (LNTH) Soars 16.8%: Is Further Upside Left in the Stock?

Zacks Investment Research·5/28/2021·↑ positive

Why Lantheus Stock Is Soaring Today

The Motley Fool·5/27/2021·↑ positive

LNTH Stock Price: Over 20% Increase Pre-Market Explanation

Pulse2·5/27/2021·↑ positive

Is the Options Market Predicting a Spike in Lantheus Holdings (LNTH) Stock?

Zacks Investment Research·5/24/2021·↓ negative